Maitake (Grifola frondosa)
Japanese 'dancing mushroom' with preliminary RCT signal for postprandial glucose and immune-cell modulation.
Why
Maitake (Grifola frondosa) is a Japanese culinary and medicinal mushroom. Small RCTs report modest reductions in postprandial glucose and changes in lipid profile (Konno 2002, Manohar 2002). The D-fraction polysaccharide extract has been studied for immune effects in cancer adjunct contexts in Japan, though Western RCT evidence remains preliminary.
How it works
β-1,6-glucan side chains on β-1,3-glucan backbone activate innate immune cells via Dectin-1 and complement receptor 3. Insulin-sensitising effects via PI3K/Akt pathway documented in preclinical models.
Expected onset · Metabolic effects over 4–8 weeks; immune effects within weeks
How to take
Dosage
Standardised D-fraction extract: 1–3 mg/kg/day. Whole mushroom powder: 3–7 g/day.
Timing
Once daily, with meals
On the label
Dual-extract Grifola frondosa with stated β-glucan content. D-fraction is the studied extract for immune indications. Avoid mycelium-on-grain products.
Ideal for
Adults exploring functional mushroom options for immune or metabolic support; people who include mushrooms in their diet.
Safety
Evidence
Konno 2001 small trial in T2DM: maitake powder reduced fasting glucose and HbA1c modestly. Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.
Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.
Where to get it
Shop Maitake (Grifola frondosa) on AmazonSponsored · As an Amazon Associate, Healicus earns from qualifying purchases.